Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-26 19:21 | 2021-07-22 | N/A | N/A | TEACHERS INSURANCE & ANNUITY ASSOCIATION OF AMERICA | 10% owner | Other | BUY | $10.18 | 491,159 | $5,000,000 | 4,970,417 | +11.0% |
| 2021-07-27 04:35 | 2021-07-26 | BASE | N/A | ANDERSON EDWARD T | Director, 10% owner | Other | BUY | $24.00 | 166,666 | $3,999,984 | 31,250 | +100.0% |
| 2021-07-27 04:36 | 2021-07-26 | BASE | N/A | NBVM GP, LLC | 10% owner | Other | BUY | $24.00 | 135,416 | $3,249,984 | 1,987,084 | +7.3% |
| 2021-07-27 01:01 | 2021-07-22 | JAKK | JAKKS PACIFIC INC | Benefit Street Partners LLC | 10% owner | Games, Toys & Children's Vehicles (No Dolls & Bicycles) | BUY | $10.32 | 583,500 | $6,022,654 | 1,356,639 | +75.5% |
| 2021-07-24 00:05 | 2021-07-23 | PYCR | N/A | MUELLER CHARLES STEVEN | Officer - Chief Revenue Officer | Other | BUY | $23.00 | 55,000 | $1,265,000 | 55,000 | +100.0% |
| 2021-07-24 02:04 | 2021-07-22 | HCWB | HCW Biologics Inc. | Wong Hing C | Director, Officer - Chief Executive Officer | Pharmaceutical Preparations | BUY | $8.00 | 627,500 | $5,020,000 | 15,255,618 | +4.3% |
| 2021-07-23 13:49 | 2021-07-16 | OBTX | Everything Blockchain, Inc. | ROSENBERG PAUL | Director, 10% owner | Services-Prepackaged Software | BUY | $11.11 | 225,000 | $2,499,998 | 2,625,528 | +9.4% |
| 2021-07-24 00:34 | 2021-07-16 | IMRA | Enliven Therapeutics, Inc. | Bonita David P | Director, 10% owner | Pharmaceutical Preparations | BUY | $6.00 | 1,666,666 | $9,999,996 | 4,199,068 | +65.8% |
| 2021-07-24 00:31 | 2021-07-21 | FST | N/A | Chatham Asset Management, LLC | 10% owner | Other | BUY | $11.65 | 395,000 | $4,601,276 | 3,372,362 | +13.3% |
| 2021-07-24 02:32 | 2021-07-22 | HCWB | HCW Biologics Inc. | GARRETT SCOTT T | Director | Pharmaceutical Preparations | BUY | $8.00 | 125,000 | $1,000,000 | 125,000 | +100.0% |
| 2021-07-24 00:30 | 2021-07-16 | IMRA | Enliven Therapeutics, Inc. | ORBIMED ADVISORS LLC | Director, 10% owner | Pharmaceutical Preparations | BUY | $6.00 | 1,666,666 | $9,999,996 | 4,199,068 | +65.8% |
| 2021-07-22 23:40 | 2021-07-22 | CLOE | Digital Ally Inc. | Yntegra Capital Investments, LLC | 10% owner | Services-Miscellaneous Amusement & Recreation | BUY | $10.00 | 571,859 | $5,718,590 | 571,859 | +100.0% |
| 2021-07-22 23:40 | 2021-07-22 | CLOE | Digital Ally Inc. | MacLean Felipe | Director, Officer, 10% owner - Chief Executive Officer | Services-Miscellaneous Amusement & Recreation | BUY | $10.00 | 571,859 | $5,718,590 | 571,859 | +100.0% |
| 2021-07-22 23:10 | 2021-07-20 | ERAS | Erasca, Inc. | Chen Bihua | Director | Pharmaceutical Preparations | BUY | $16.00 | 950,000 | $15,200,000 | 10,505,553 | +9.9% |
| 2021-07-22 23:34 | 2021-05-24 | PACE | Nerdy Inc. | LIGHT STREET CAPITAL MANAGEMENT, LLC | 10% owner | Services-Educational Services | BUY | $10.12 | 192,200 | $1,945,641 | 5,025,000 | +4.0% |
| 2021-07-22 23:46 | 2021-07-20 | TCRX | TScan Therapeutics, Inc. | Westphal Christoph H | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $15.00 | 133,333 | $1,999,995 | 1,278,838 | +11.6% |
| 2021-07-22 23:06 | 2021-07-20 | TCRX | TScan Therapeutics, Inc. | BAKER BROS. ADVISORS LP | Director | Biological Products, (No Diagnostic Substances) | BUY | $15.00 | 1,425,000 | $21,375,000 | 1,320,302 | +100.0% |
| 2021-07-22 19:45 | 2021-07-01 | N-A | N/A | BLACKROCK FINANCIAL MANAGEMENT INC/DE | 10% owner, Other | Other | BUY | $9.98 | 4,959,920 | $49,500,000 | 9,969,920 | +99.0% |
| 2021-07-21 23:36 | 2021-07-19 | SGHT | Sight Sciences, Inc. | D1 Capital Partners L.P. | 10% owner | Surgical & Medical Instruments & Apparatus | BUY | $24.00 | 700,000 | $16,800,000 | 5,852,036 | +13.6% |
| 2021-07-22 00:24 | 2021-07-19 | AFIB | Acutus Medical Inc. | Bonita David P | Director, 10% owner | Surgical & Medical Instruments & Apparatus | BUY | $14.00 | 1,071,428 | $14,999,992 | 1,677,361 | +176.8% |
| 2021-07-21 22:14 | - | COSM | Cosmos Health Inc. | Siokas Grigorios | Director, Officer, 10% owner - Chief Executive Officer | Wholesale-Drugs, Proprietaries & Druggists' Sundries | BUY | $6.00 | 208,333 | $1,249,998 | 7,324,517 | +2.9% |
| 2021-07-21 23:40 | 2021-07-19 | RPID | RAPID MICRO BIOSYSTEMS, INC. | Bain Capital Life Sciences Investors, LLC | 10% owner | Laboratory Analytical Instruments | BUY | $20.00 | 100,000 | $2,000,000 | 8,434,560 | +1.2% |
| 2021-07-21 23:12 | 2021-07-19 | MCG | Soho House & Co Inc. | EIN MARK | Director | Hotels & Motels | BUY | $14.00 | 125,000 | $1,750,000 | 138,333 | +937.5% |
| 2021-07-21 21:02 | 2021-07-19 | MTEM | N/A | BIOTECH TARGET N V | 10% owner | Other | BUY | $7.05 | 244,382 | $1,722,502 | 9,787,003 | +2.6% |
| 2021-07-22 00:30 | 2021-07-19 | AFIB | Acutus Medical Inc. | ORBIMED ADVISORS LLC | Director, 10% owner | Surgical & Medical Instruments & Apparatus | BUY | $14.00 | 1,071,428 | $14,999,992 | 1,677,361 | +176.8% |
| 2021-07-22 00:14 | 2021-07-19 | AFIB | Acutus Medical Inc. | Flynn James E | Director, 10% owner, Other | Surgical & Medical Instruments & Apparatus | BUY | $14.00 | 1,071,428 | $14,999,992 | 3,438,589 | +45.3% |
| 2021-07-21 00:03 | 2021-07-16 | FST | N/A | Chatham Asset Management, LLC | 10% owner | Other | BUY | $11.74 | 147,000 | $1,725,486 | 2,977,362 | +5.2% |
| 2021-07-21 00:54 | 2021-07-20 | IMGO | N/A | Heron Patrick J | Director | Other | BUY | $16.00 | 187,500 | $3,000,000 | 145,918 | +100.0% |
| 2021-07-21 04:39 | 2021-07-19 | RPID | RAPID MICRO BIOSYSTEMS, INC. | Longitude Capital Partners II, LLC | 10% owner | Laboratory Analytical Instruments | BUY | $20.00 | 150,000 | $3,000,000 | 150,000 | +100.0% |
| 2021-07-21 01:05 | 2021-07-20 | IMGO | N/A | Clarus Lifesciences III, L.P. | 10% owner | Other | BUY | $16.00 | 150,000 | $2,400,000 | 3,375,037 | +4.7% |
| 2021-07-20 21:55 | 1999-01-01 | ACCR | N/A | Jensen Patrick J | Other | Other | BUY | $25,000.00 | 160,050,000 | $4,001,250,000,000 | 26,934,379 | +100.0% |
| 2021-07-20 21:14 | 2021-05-19 | ACCR | N/A | Jensen Patrick J | Other | Other | BUY | $25,000.00 | 160,050,000 | $4,001,250,000,000 | 27,106,879 | +100.0% |
| 2021-07-19 23:43 | 2021-07-16 | N/A | Morgan Stanley Direct Lending Fund | MS Credit Partners Holdings Inc. | 10% owner | Other | BUY | $20.93 | 765,066 | $16,012,829 | 4,489,016 | +20.5% |
| 2021-07-20 02:03 | 2021-07-15 | IMGO | N/A | Omega Fund VI, L.P. | Other | Other | BUY | $16.00 | 250,000 | $4,000,000 | 250,000 | +100.0% |
| 2021-07-19 23:21 | 2021-07-15 | GIM | Saba Capital Income & Opportunities Fund II | Saba Capital Management, L.P. | 10% owner | Other | BUY | $5.54 | 1,014,987 | $5,620,998 | 27,241,055 | +3.9% |
| 2021-07-20 00:11 | 2021-07-19 | PECO | Phillips Edison & Company, Inc. | Edison Jeffrey | Director, Officer - Chairman and CEO | Real Estate Investment Trusts | BUY | $28.00 | 50,000 | $1,400,000 | 76,351 | +189.7% |
| 2021-07-19 23:05 | 2021-07-15 | N/A | N/A | Alberta Investment Management Corp | 10% owner | Other | BUY | $22.19 | 540,784 | $12,000,000 | 3,060,891 | +21.5% |
| 2021-07-19 16:47 | 2021-07-06 | OBTX | Everything Blockchain, Inc. | Hawkins Michael W | Director, Officer - CFO | Services-Prepackaged Software | BUY | $17.56 | 275,000 | $4,829,495 | 350,000 | +366.7% |
| 2021-07-19 22:47 | 2021-07-16 | REI | RING ENERGY, INC. | Kruse William R | 10% owner | Crude Petroleum & Natural Gas | BUY | $2.59 | 600,000 | $1,554,000 | 12,175,682 | +5.2% |
| 2021-07-20 02:33 | 2021-07-15 | CRCT | Cricut, Inc. | Abdiel Capital Management, LLC | 10% owner | Special Industry Machinery, NEC | BUY | $33.77 | 123,291 | $4,164,104 | 4,215,297 | +3.0% |
| 2021-07-19 23:30 | 2021-07-15 | N/A | N/A | ROSENBERG RALPH F | Director | Other | BUY | $26.89 | 37,189 | $1,000,000 | 37,189 | +100.0% |
| 2021-07-16 23:52 | 2021-07-14 | GBX | GREENBRIER COMPANIES INC | FURMAN WILLIAM A | Director, Officer - Chairman & CEO | Railroad Equipment | BUY | $43.08 | 100,000 | $4,307,660 | 672,518 | +17.5% |
| 2021-07-16 17:16 | 2021-07-15 | N/A | N/A | TEACHERS INSURANCE & ANNUITY ASSOCIATION OF AMERICA | 10% owner | Other | BUY | $10.15 | 985,222 | $10,000,000 | 4,479,257 | +28.2% |
| 2021-07-16 23:21 | 2021-07-16 | IMRA | Enliven Therapeutics, Inc. | Bonita David P | Director, 10% owner | Pharmaceutical Preparations | BUY | $6.00 | 1,666,666 | $9,999,996 | 1,666,666 | +100.0% |
| 2021-07-17 04:13 | 2021-07-14 | ENVX | Enovix Corp | Park West Asset Management LLC | 10% owner | Miscellaneous Electrical Machinery, Equipment & Supplies | BUY | $14.00 | 2,142,857 | $29,999,998 | 6,442,857 | +49.8% |
| 2021-07-16 23:25 | 2021-07-14 | REI | RING ENERGY, INC. | Kruse William R | 10% owner | Crude Petroleum & Natural Gas | BUY | $2.77 | 1,010,000 | $2,793,862 | 11,575,682 | +9.6% |
| 2021-07-17 00:11 | 2021-06-18 | DRTT | DIRTT ENVIRONMENTAL SOLUTIONS LTD | 22NW, LP | 10% owner | Services-Prepackaged Software | BUY | $4.34 | 1,714,357 | $7,443,224 | 10,129,887 | +20.4% |
| 2021-07-16 23:27 | 2021-07-16 | IMRA | Enliven Therapeutics, Inc. | ORBIMED ADVISORS LLC | Director, 10% owner | Pharmaceutical Preparations | BUY | $6.00 | 1,666,666 | $9,999,996 | 1,666,666 | +100.0% |
| 2021-07-17 00:01 | 2021-07-14 | S | SentinelOne, Inc. | Loeb Daniel S | 10% owner | Services-Prepackaged Software | BUY | $44.90 | 200,000 | $8,980,380 | 2,193,575 | +10.0% |
| 2021-07-16 03:24 | 2021-07-14 | IVAN | SES AI Corp | FRIEDLAND ROBERT M | Director, Officer - Chairman and CEO | Miscellaneous Electrical Machinery, Equipment & Supplies | BUY | $10.00 | 100,000 | $1,000,000 | 100,000 | +100.0% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.